247 related articles for article (PubMed ID: 34544131)
1. Selective functional inhibition of a tumor-derived p53 mutant by cytosolic chaperones identified using split-YFP in budding yeast.
Denney AS; Weems AD; McMurray MA
G3 (Bethesda); 2021 Sep; 11(9):. PubMed ID: 34544131
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic chaperones mediate quality control of higher-order septin assembly in budding yeast.
Johnson CR; Weems AD; Brewer JM; Thorner J; McMurray MA
Mol Biol Cell; 2015 Apr; 26(7):1323-44. PubMed ID: 25673805
[TBL] [Abstract][Full Text] [Related]
3. Kinetic partitioning during de novo septin filament assembly creates a critical G1 "window of opportunity" for mutant septin function.
Schaefer RM; Heasley LR; Odde DJ; McMurray MA
Cell Cycle; 2016 Sep; 15(18):2441-53. PubMed ID: 27398993
[TBL] [Abstract][Full Text] [Related]
4. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent.
Whitesell L; Sutphin PD; Pulcini EJ; Martinez JD; Cook PH
Mol Cell Biol; 1998 Mar; 18(3):1517-24. PubMed ID: 9488468
[TBL] [Abstract][Full Text] [Related]
5. Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells.
Li D; Marchenko ND; Schulz R; Fischer V; Velasco-Hernandez T; Talos F; Moll UM
Mol Cancer Res; 2011 May; 9(5):577-88. PubMed ID: 21478269
[TBL] [Abstract][Full Text] [Related]
6. CHIP chaperones wild type p53 tumor suppressor protein.
Tripathi V; Ali A; Bhat R; Pati U
J Biol Chem; 2007 Sep; 282(39):28441-28454. PubMed ID: 17666403
[TBL] [Abstract][Full Text] [Related]
7. Chaperone requirements for de novo folding of
Hassell D; Denney A; Singer E; Benson A; Roth A; Ceglowski J; Steingesser M; McMurray M
Mol Biol Cell; 2022 Oct; 33(12):ar111. PubMed ID: 35947497
[TBL] [Abstract][Full Text] [Related]
8. Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53.
King FW; Wawrzynow A; Höhfeld J; Zylicz M
EMBO J; 2001 Nov; 20(22):6297-305. PubMed ID: 11707401
[TBL] [Abstract][Full Text] [Related]
9. Higher-order septin assembly is driven by GTP-promoted conformational changes: evidence from unbiased mutational analysis in Saccharomyces cerevisiae.
Weems AD; Johnson CR; Argueso JL; McMurray MA
Genetics; 2014 Mar; 196(3):711-27. PubMed ID: 24398420
[TBL] [Abstract][Full Text] [Related]
10. The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation.
Esser C; Scheffner M; Höhfeld J
J Biol Chem; 2005 Jul; 280(29):27443-8. PubMed ID: 15911628
[TBL] [Abstract][Full Text] [Related]
11. MDM2 chaperones the p53 tumor suppressor.
Wawrzynow B; Zylicz A; Wallace M; Hupp T; Zylicz M
J Biol Chem; 2007 Nov; 282(45):32603-12. PubMed ID: 17848574
[TBL] [Abstract][Full Text] [Related]
12. Disrupting progression of the yeast Hsp90 folding pathway at different transition points results in client-specific maturation defects.
Hohrman K; Gonçalves D; Morano KA; Johnson JL
Genetics; 2021 Mar; 217(3):. PubMed ID: 33789348
[TBL] [Abstract][Full Text] [Related]
13. Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90.
Blagosklonny MV; Toretsky J; Bohen S; Neckers L
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8379-83. PubMed ID: 8710879
[TBL] [Abstract][Full Text] [Related]
14. Mutation of essential Hsp90 co-chaperones SGT1 or CNS1 renders yeast hypersensitive to overexpression of other co-chaperones.
Johnson JL; Zuehlke AD; Tenge VR; Langworthy JC
Curr Genet; 2014 Nov; 60(4):265-76. PubMed ID: 24923785
[TBL] [Abstract][Full Text] [Related]
15. Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions.
Walerych D; Olszewski MB; Gutkowska M; Helwak A; Zylicz M; Zylicz A
Oncogene; 2009 Dec; 28(48):4284-94. PubMed ID: 19749793
[TBL] [Abstract][Full Text] [Related]
16. Role of molecular chaperones in biogenesis of the protein kinome.
Mandal AK; Theodoraki MA; Nillegoda NB; Caplan AJ
Methods Mol Biol; 2011; 787():75-81. PubMed ID: 21898228
[TBL] [Abstract][Full Text] [Related]
17. Hsp110 chaperones control client fate determination in the hsp70-Hsp90 chaperone system.
Mandal AK; Gibney PA; Nillegoda NB; Theodoraki MA; Caplan AJ; Morano KA
Mol Biol Cell; 2010 May; 21(9):1439-48. PubMed ID: 20237159
[TBL] [Abstract][Full Text] [Related]
18. The co-chaperone Hch1 regulates Hsp90 function differently than its homologue Aha1 and confers sensitivity to yeast to the Hsp90 inhibitor NVP-AUY922.
Armstrong H; Wolmarans A; Mercier R; Mai B; LaPointe P
PLoS One; 2012; 7(11):e49322. PubMed ID: 23166640
[TBL] [Abstract][Full Text] [Related]
19. The role of p23, Hop, immunophilins, and other co-chaperones in regulating Hsp90 function.
Cox MB; Johnson JL
Methods Mol Biol; 2011; 787():45-66. PubMed ID: 21898226
[TBL] [Abstract][Full Text] [Related]
20. Functional interactions between Hsp90 and the co-chaperones Cns1 and Cpr7 in Saccharomyces cerevisiae.
Tesic M; Marsh JA; Cullinan SB; Gaber RF
J Biol Chem; 2003 Aug; 278(35):32692-701. PubMed ID: 12788914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
